Abivax raises $800 million and jumps 40% on the stock market
The French biotech Abivax finalizes an $800 million fundraising.
Published 3sem2 sources✓ ConfirmedMajorupdated 2sem
Lire en français
≈ 15s
40 %
Abivax raises $800 million and jumps 40% on the stock market
The fact
Its stock surged nearly 40% in a single session.
This operation aims to fund advanced clinical trials.
2 sources — click a link to read an article on the topic: